• CO96 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Baseline Patient Characteristics: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo

    Jul 1, 2022, 00:00

  • EE400 Cost-Effectiveness Analysis of Fampridine for Multiple Sclerosis Treatment in China

    Jul 1, 2022, 00:00

  • HSD91 The Influence of Patient and Hospital Characteristics in Sugammadex Usage Under General Anesthesia

    Jul 1, 2022, 00:00

  • EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study

    Jul 1, 2022, 00:00

  • EE330 Spill-over of Medical Cost for Blue Cross and Blue Shield of Louisiana Members with Differing Severity of COVID-19 Infection

    Jul 1, 2022, 00:00

  • P6 Development of Subjective Financial Distress Questionnaire (SFDQ) for Measuring Financial Toxicity Among Cancer Patients Undergoing Radiation Therapy

    Jul 1, 2022, 00:00

  • EE120 Costs Attributable to Heart Failure and Worsening Heart Failure with Reduced Ejection Fraction in Colombia

    Jul 1, 2022, 00:00

  • EE75 The Economic Value of HPV Multi-Genotype Detection Technology

    Jul 1, 2022, 00:00

  • P50 Comparison of the EQ-5D-5L and Aqol-8D in a Cohort of People with Idiopathic Pulmonary Fibrosis in Australia

    Jul 1, 2022, 00:00

  • EPH96 Infant Immunization Coverage in a Colombian Poor Municipality in the Post-Conflict Era

    Jul 1, 2022, 00:00

  • CO131 Systematic Literature Review Assessing the Clinical Outcomes of Adeno-Associated Virus (AAV) Gene Transfer Therapies in Duchenne Muscular Dystrophy (DMD)

    Jul 1, 2022, 00:00

  • EE357 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration and Impacts on Health Care Resource Usage: A Population Based Analysis of Real World Evidence

    Jul 1, 2022, 00:00

  • EE308 Real-World Treatment Patterns and Costs in Relapsed and Refractory Diffuse Large B-Cell Lymphoma in the United States

    Jul 1, 2022, 00:00

  • MSR48 Estimating Event-Specific Probabilities and Conditional Time-to-Event Distributions from Censored Competing Risks Data

    Jul 1, 2022, 00:00

  • EE111 Adoption of Piecewise Modelling: A Review of Nice Health Technology Appraisals in Oncology

    Jul 1, 2022, 00:00

  • HTA68 Determinants of Funding with Managed Entry Agreements, As Part of Health Technology Assessment Decision-Making Processes: Empirical Evidence from Cancer Therapies in Four Countries

    Jul 1, 2022, 00:00

  • HPR39 Characterizing US Payer Coverage Policies and Associated Rationale When Those Policies Differ from the Institute for Clinical and Economic Review (ICER) Assessment Determinations

    Jul 1, 2022, 00:00

  • EE171 Evaluation of the Behavior of the Dispensing of Drugs for Breast Cancer in a Cohort of Patients in Colombia

    Jul 1, 2022, 00:00

  • CO158 A Comparison of the Clinical and Economic Outcomes Associated with Short-Acting Bronchodilator Modes of Delivery Among Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Jul 1, 2022, 00:00

  • CO69 Test-Retest Reliability of the PDQ-Exercise

    Jul 1, 2022, 00:00

  • EPH56 A Systematic Review on the Global Clinical Burden of Pneumonia Among Adults Aged 50 and Older

    Jul 1, 2022, 00:00

  • EPH68 Targeted Therapy and Treatment Trends in Locally Advanced Head and Neck Cancer in Taiwan: A Population-Based Retrospective Study

    Jul 1, 2022, 00:00

  • EE121 Numbers Needed to Treat and Costs per Improved Outcome Among Treatments for Myasthenia Gravis

    Jul 1, 2022, 00:00

  • CO82 Racial Disparity Following Surgical Care for Patients Sustaining Gustilo Type III Tibial Fractures Using Propensity-Score Matched Cohorts in a Medicaid Database

    Jul 1, 2022, 00:00

  • EE211 Cost of Long COVID Following Severe Disease - a US Healthcare Database Analysis

    Jul 1, 2022, 00:00

  • HSD56 Hidradenitis Suppurativa in the Pediatric Population

    Jul 1, 2022, 00:00

  • EE87 Economic Evauation of Adalimumab Biosimilars and JAK Inhibitors for the Treatment of Moderate-to-Severe Rheumatoid Arthritis

    Jul 1, 2022, 00:00

  • HPR64 What Goes in Must Come Out: An Analysis of NICE Recommendations for Drugs Exiting Managed (Early) Access in England

    Jul 1, 2022, 00:00

  • P38 Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-Severe Asthma: Liberty Asthma Voyage Study

    Jul 1, 2022, 00:00

  • EPH70 Equity in Economic Evaluations of Early Childhood Development Interventions in Low-and Middle-Income Countries: Scoping Review

    Jul 1, 2022, 00:00

  • EE300 Economic Burden of Transfusion-Dependent Chinese Adult -Thalassemia Patients from Social Perspective

    Jul 1, 2022, 00:00

  • P32 Power Implications of Estimator Choice in Synthetic Control Arm Analyses: Results from a Simulation Comparing Average Treatment Effects on the Treated and Untreated Under Propensity Score Weighting

    Jul 1, 2022, 00:00

  • P59 Comparative Efficacy and Safety of Ozanimod and Ponesimod for Relapsing Multiple Sclerosis: A Matching-Adjusted Indirect Comparison

    Jul 1, 2022, 00:00

  • HTA69 Precise Analysis of the State HTA Progress in Ukraine: Results of the 1st Year of Implementation and Impact

    Jul 1, 2022, 00:00

  • HPR35 The Impact of Biosimilar Trastuzumab on Drug Spending in Australia

    Jul 1, 2022, 00:00

  • CO90 A Systematic Literature Review of the Clinical Burden in Patients with Myelodysplastic Syndromes

    Jul 1, 2022, 00:00

  • HTA72 Survival Extrapolation for Immuno-Oncology Drugs: Pessimism or Optimism? a Targeted Literature Review and a Validation-Based Case Study

    Jul 1, 2022, 00:00

  • MSR49 Assessing the Impact of COVID-19 on the Healthcare Resource Utilization and Treatment in High Incidence Oncological Conditions

    Jul 1, 2022, 00:00

  • EE303 Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States

    Jul 1, 2022, 00:00

  • EE348 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Costa Rica

    Jul 1, 2022, 00:00

  • EE2 A Cost-Effectiveness Analysis Comparing Obesity Drug Treatments from a U.S. Payer Perspective

    Jul 1, 2022, 00:00

  • EE322 Direct Medical and Indirect Absenteeism Costs Among Working Adult ADHD Patients in the United States

    Jul 1, 2022, 00:00

  • CO31 Health Equity Considerations in Minority Groups with Type 1 and 2 Diabetes in the COVID-19 Era: Care Utilizations and Costs

    Jul 1, 2022, 00:00

  • EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model

    Jul 1, 2022, 00:00

  • EPH72 Potential Adverse Effects of Passive Immunization Against Respiratory Syncytial Virus (RSV) in Low-Risk Infants in the United States

    Jul 1, 2022, 00:00

  • EE371 Cost Analysis of Birth Outcomes in the Helping Appalachian Parents and Infants Public Health Initiative

    Jul 1, 2022, 00:00

  • EE58 Value-Based Pricing of an Ebola Vaccine in Resource-Constrained Countries Based on Cost-Effectiveness Analysis

    Jul 1, 2022, 00:00

  • HSD68 Treatment Intensification in Diabetes: A Perspective from Latin American Guidelines in Patients with an Oral First Line Antidiabetic Drug Regimen

    Jul 1, 2022, 00:00

  • Machine Learning in HEOR

    Jul 1, 2022, 00:00

  • CO9 Updated Evidence on the Use of Solid Oral Dosage Forms in Adults with Neurological Disorders and Swallowing Difficulties: A Scoping Review

    Jul 1, 2022, 00:00

  • EE181 An Economic Model to Estimate Costs of Cytokine Release Syndrome (CRS) and Neurological Events (NE) Among Patients Treated with Lisocabtagene Maraleucel (LISO-CEL) or Axicabtagene Ciloleucel (AXI-CEL) for Second-LINE (2L) Treatment of ...

    Jul 1, 2022, 00:00

  • EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic

    Jul 1, 2022, 00:00

  • MSR39 An Approach to Quantifying and Appending Missing Prescription Utilization for Asthma Patients in Health Plan Claims Data Utilizing Point-of-Sale Data

    Jul 1, 2022, 00:00

  • EE231 Calculating the Indirect Cost of Disease Recurrence and Subsequent Premature Mortality in Patients Diagnosed with Early-Stage Hepatocellular Carcinoma (HCC) in the United States (US)

    Jul 1, 2022, 00:00

  • HSD11 Microbiological Examination of Nurses' Hand Hygiene

    Jul 1, 2022, 00:00

  • EE70 CAR-T Treatment Costs Beyond Therapy Acquisition Costs in Multiple Myeloma Patients

    Jul 1, 2022, 00:00

  • EE478 Using Real World Evidence to Generate Cost-Effectiveness Analysis of Fibrinolytic Therapy in Patients with ST-Segment Elevation Myocardial Infarction in a Limited Resource Country

    Jul 1, 2022, 00:00

  • EE265 Focal Segmental Glomerulosclerosis (FSGS) in Adults: A Retrospective Analysis of US Prevalence and Impacts of Proteinuria and Kidney Function Decline on Healthcare Resource Utilization (HRU) and Costs

    Jul 1, 2022, 00:00

  • EE319 Setting a Value-Based Price for Xanomeline-Trospium As Treatment for Markedly Ill Schizophrenia

    Jul 1, 2022, 00:00

  • EE88 Cost-Effectiveness Analysis of Risk Scoring Model in Population-Based Oral Cancer Screening Program of Taiwan

    Jul 1, 2022, 00:00

  • HTA14 A Systematic Review and Meta-Analysis of Factors Affecting Health Technology Assessments in Healthcare

    Jul 1, 2022, 00:00

  • EE152 Early Economic Analysis of Resorbable Bioinductive Implant in the Treatment of Full Thickness Rotator Cuff Tears

    Jul 1, 2022, 00:00

  • EE359 US Cost-Effectiveness of Chimeric Antigen Receptor T-Cell (CAR T) Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL), Considering Infusion Setting and Payor Claims Data

    Jul 1, 2022, 00:00

  • HSD110 JAV-Raras: Comparative Analysis of Patient’s Costs According to Clinical and Therapeutic Protocol (PCDT) and Current Clinical Practice for Osteogenesis Imperfecta (OI) in Brazilian Public Healthcare System

    Jul 1, 2022, 00:00

  • EPH18 Real-World Biomarker Positivity Rates Among Patients with Advanced Non-Small Cell Lung Cancer in the United States

    Jul 1, 2022, 00:00

  • EPH168 Antipsychotic Adherence and Persistence Among Patients with Schizophrenia Receiving Long-Acting Injectables Versus Oral Formulations: A Systematic Review

    Jul 1, 2022, 00:00

  • CO61 Incremental Healthcare Costs for Cardiac Surgery Patients with New-Onset Post-Operative Atrial Fibrillation

    Jul 1, 2022, 00:00

  • HTA57 UK Market Access: The Evolving Scope of NICE and NHSE Specialised Commissioning

    Jul 1, 2022, 00:00

  • EPH101 Factors Associated with Biologic Disease-Modifying Antirheumatic Drugs Utilization in Rheumatoid Arthritis Patients

    Jul 1, 2022, 00:00

  • CO53 Comparison of Real-World Later-Line Treatment Outcomes in Patients with Microsatellite-Instability High (MSI-H) Versus Microsatellite-Stable (MSS) Metastatic Colorectal Cancer (mCRC) in the United States (US)

    Jul 1, 2022, 00:00

  • Clinical Trial Methods and Applications in HEOR

    Jul 1, 2022, 00:00

  • HTA9 Differences in Guidance on Pro Evidentiary Requirements across Key European HTA Agencies

    Jul 1, 2022, 00:00

  • EPH49 Relationship between Pregnancy-Related Risk Factors and Receipt of Postpartum Care Among Texas Medicaid Enrollees

    Jul 1, 2022, 00:00

  • CO106 Efficacy of FDA-Approved Disease-Modifying Therapies (DMTS) Versus Active Comparator Medications for Relapsing-Remitting Multiple Sclerosis: A Systematic Review

    Jul 1, 2022, 00:00

  • EPH129 Blue Cross and Blue Shield of Louisiana's COVID-19 Outbreak Simulation- Deterministic SEIR Modeling

    Jul 1, 2022, 00:00

  • EE151 Cost Minimization Analysis Evaluating Turoctocog ALFA (NOVOEIGHT®) and Product X As Prophylaxis Treatment for Paediatric and Adult Patients with Severe Haemophilia a in China

    Jul 1, 2022, 00:00

  • HSD57 Factors Associated with Remote Patient Monitoring (RPM) Services Provision By Hospitals and Healthcare Systems in the United States

    Jul 1, 2022, 00:00

  • Tackling Reimbursement Challenges to Fair Access to Medicine

    Jul 1, 2022, 00:00

  • HTA42 The Budget Impact Analysis of Acute Stroke Centre Expansion in Ministry of Health Malaysia

    Jul 1, 2022, 00:00

  • EE117 Estimating Economic and Disease Burden of Snakebite in South East Asia: A Decision Analytic Model

    Jul 1, 2022, 00:00

  • EE283 Cost-Effectiveness Analysis of Cell-Based Therapy for Patients with Non-Alcoholic Fatty Liver Disease

    Jul 1, 2022, 00:00

  • MSR51 Sickle Cell Disease Hospitalizations and Social Determinants of Care: An Investigation into the Disproportionate Burden of Disease

    Jul 1, 2022, 00:00

  • EE177 Economic Impact of Contrast-Induced Nephropathy in Percutaneous Coronary Intervention: A Medicare Payer Perspective

    Jul 1, 2022, 00:00

  • HTA37 Review of Utility Values Used in the State Health Technology Assessment in Ukraine

    Jul 1, 2022, 00:00

  • EE14 A Systematic Review of Preference Elicitation Techniques Used in Valuing Children's Health-Related Quality-of-Life

    Jul 1, 2022, 00:00

  • Patient Self-Care and Caregiver Contribution to Patient Self-Care of Chronic Conditions: What Is Dyadic and What It Is Not

    Jul 1, 2022, 00:00

  • EE437 Healthcare Resource Utilization and Costs in Patients with Multiple Myeloma Who Received 1 to 3 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and Exposed to (AND DISCONTINUED) Lenalidomide in the ...

    Jul 1, 2022, 00:00

  • EE153 Budget Impact Analysis of Introducing Mobocertinib for Locally Advanced or Metastatic Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small-Cell Lung Cancer in the United States from the Payer Perspective

    Jul 1, 2022, 00:00

  • EE301 Improvement in Work Productivity Loss and Associated Costs for Crohn's Disease Patients Receiving Ustekinumab in the United States: Findings from a Real-World Survey

    Jul 1, 2022, 00:00

  • EE323 A Targeted Literature Review of the Cost-Effectiveness of Erythropoiesis-Stimulating Agents As Standard Care for the Treatment of Chemotherapy-Induced Anemia

    Jul 1, 2022, 00:00

  • EE409 Targeted Literature Review (TLR) of the Economic Burden and Cost-Effectiveness of Treatments for Advanced Non-Small Cell Lung Cancer (ANSCLC)

    Jul 1, 2022, 00:00

  • EE491 Cost-Effectiveness of paclitaxel Monotherapy Versus paclitaxel Plus Bevacizumab Combination Therapy in Triple-Negative Breast Cancer

    Jul 1, 2022, 00:00

  • HSD84 Quality of Discharge Teaching and Readiness for Hospital Discharge Among Family Caregivers of Medicine Patients Hospitalized at a Tertiary Care Hospital in Karachi, Pakistan

    Jul 1, 2022, 00:00

  • Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study

    Jul 1, 2022, 00:00

  • Economic Evaluation

    Jul 1, 2022, 00:00

  • EE5 Assessment of Value Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test in a Medicare Population

    Jul 1, 2022, 00:00

  • MSR37 Methods for Recovering Missing Longitudinal Biomarker Values from Electronic Health Record Data

    Jul 1, 2022, 00:00

  • MSR24 Assessing the Accuracy of a Semi-Markov Model (SMM) with Split Local and Distant Recurrence Health States in Predicting Overall Survival (OS) for Muscle Invasive Urothelial Carcinoma (MIUC)

    Jul 1, 2022, 00:00

  • EE15 Economic Burden of Transfusion-Dependent Beta-Thalassemia in the United States

    Jul 1, 2022, 00:00

  • EPH136 Factors Associated with Pneumococcal Vaccine Uptake Among Vulnerable Populations in the Primary Care Setting

    Jul 1, 2022, 00:00

  • HSD99 Pharmacist-Led Interventions for Reducing Health Disparities: A Systematic Review

    Jul 1, 2022, 00:00

  • CO16 Association between Adherence and Worsening Heart Failure Events in an Employed Population

    Jul 1, 2022, 00:00

  • CO100 Correlations between Patient- and Caregiver-Reported Pruritus from PEDFIC 1: Evaluation of Prucision Data in Patients with Progressive Familial Intrahepatic Cholestasis

    Jul 1, 2022, 00:00

  • EE356 Budget Impact Analysis on Blinatumomab for the Treatment of Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R BCP-ALL)

    Jul 1, 2022, 00:00

  • HTA22 The Challenges Medical Device Technologies Pose to Health Technology Assessment Methods and Implications for the Evaluation of Future Digital Devices

    Jul 1, 2022, 00:00

  • CO129 Pharmacist-Led Medication Review to Reduce Antiretroviral Therapy Errors in HIV/AIDS Patients: A Systematic Review

    Jul 1, 2022, 00:00

  • EE53 Healthcare Resource Utilization of Cervical Cancer in the Brazilian Public Healthcare System: A Claim Database Study

    Jul 1, 2022, 00:00

  • EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease

    Jul 1, 2022, 00:00

  • EE128 Early Real-World Experience with Emicizumab and Concomitant Factor VIII Replacement Products in Adult, Male People with Hemophilia A without Inhibitors

    Jul 1, 2022, 00:00

  • EE288 A Cost-Effectiveness Analysis of Biologic Compared with Chemical Disease Modifying Drugs in Treating Multiple Sclerosis in US

    Jul 1, 2022, 00:00

  • CO59 Polypharmacy and Risk of Fall-Related Hospitalization in Older Adults

    Jul 1, 2022, 00:00

  • EPH12 Health Insurance Treatment Cost of Female Infertility Associated with Anovulation Based on Real-World Health Insurance Claims Data in 2019 in Hungary

    Jul 1, 2022, 00:00

  • P35 Risk of Psychiatric and Neurological Sequelae after the COVID-19 Infection: A Retrospective Cohort Study Using Claim Data

    Jul 1, 2022, 00:00

  • EE261 Economic Burden of Hemophilia B Patients in the United States: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • EE331 The Cost-Effectiveness of Non-Drug Interventions That Reduce the Risk of Nursing Home Admissions for People Living with Dementia

    Jul 1, 2022, 00:00

  • EE204 Budgetary Impact of New Recommendations for Pneumococcal Vaccination of US Adults

    Jul 1, 2022, 00:00

  • EE230 CHARACTERISTICS OF INTERVENTIONS REPORTED BY CLINICAL PHARMACISTS AT A GENERAL HOSPITAL. A CROSS-SECTIONAL STUDY

    Jul 1, 2022, 00:00

  • EE411 Healthcare Costs of Direct Oral Anticoagulants Among Medicare Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

    Jul 1, 2022, 00:00

  • HPR36 Using Best-Worst Scaling to Identify the Important Barriers to COVID-19 Vaccination in Black Belt Region: A Pilot Study

    Jul 1, 2022, 00:00

  • HPR53 Association between Prenatal and Long-Term Visit History and Birth Outcomes Among Black Women: A Linked EMR/Claims Analysis

    Jul 1, 2022, 00:00

  • P66 Cost-Effectiveness of the Chest Pain Choice Decision Aid Versus Usual Care Among Low-Risk Chest Pain Patients Presenting to the Emergency Department

    Jul 1, 2022, 00:00

  • EPH131 Innovative Use of a Large Real-World Database for Identifying Stroke Survivors and Access to Rehabilitation in Primary Care in Brazil

    Jul 1, 2022, 00:00

  • HSD14 Reliability of Charting the Clinical Course of Chronic Hyperkalemia Treatment through an Ontology-Based Protocol Applied to Prior Authorization Drug Review Notes

    Jul 1, 2022, 00:00

  • EE221 Cost-Effectiveness of Cervical Cancer Screening Program in China

    Jul 1, 2022, 00:00

  • EPH19 Real-World Biomarker Testing Rates Among Patients with with Advanced Non-Small Cell Lung Cancer in the United States

    Jul 1, 2022, 00:00

  • P43 The Economic Burden of Idiopathic Pulmonary Fibrosis in Australia

    Jul 1, 2022, 00:00

  • MSR35 The Importance of Accounting for Heterogeneity in Economic Analysis and Best Practices for the US Setting

    Jul 1, 2022, 00:00

  • CO47 Quality of Life in Patients with Parkinson's Disease in a Third Level Hospital in Mexico

    Jul 1, 2022, 00:00

  • EE449 Outcome Assessment of Sofosbuvir / Velpatasvir for the Treatment of Patients with Hepatitis C in Colombia

    Jul 1, 2022, 00:00

  • P27 Addressing Health Barriers Using Social Determinant of Health Data

    Jul 1, 2022, 00:00

  • EE365 Assessment of Hospital Charges for Initial and/or Repeat Catheter Ablations for Atrial Fibrillation Performed in 2017, 2018, or 2019

    Jul 1, 2022, 00:00

  • The Roadmap for Implementing Value-Based Healthcare in European University Hospitals—Consensus Report and Recommendations

    Jul 1, 2022, 00:00

  • EE38 A Review of Cost Effectiveness Analysis (CEA) of Immuno-Oncologic Therapies for Squamous Cell Carcinoma Head and Neck Cancer (SCCHN): Lessons Learned

    Jul 1, 2022, 00:00

  • EE443 Economic Evaluation of Brexpiprazole As Adjunctive Treatment of Major Depressive Disorder in the Mexican National Health System

    Jul 1, 2022, 00:00

  • EE407 Cost-Effectiveness Analysis of Colon and Rectal Cancer Screening Interventions in Beneficiaries of the Instituto Mexicano Del Seguro Social

    Jul 1, 2022, 00:00

  • EE390 Co-Occurring Chronic Inflammatory Diseases (CIDS): Treatment Patterns and Healthcare Resource Utilization (HCRU) in the United States (US)

    Jul 1, 2022, 00:00

  • HTA25 What Factors Affect Social Medical Insurance Drug Listing Decision-Making in China? Evidence from the National Drug Price Negotiation in 2020

    Jul 1, 2022, 00:00

  • P46 Missing Data and Missed Opportunities: A Potential Solution to Data Gaps for Societal Perspective Economic Evaluations

    Jul 1, 2022, 00:00

  • EPH155 Analysis of the Risk Factors for Failed Back Surgery Syndrome: Real-World Evidence

    Jul 1, 2022, 00:00

  • HSD39 Characteristics and Treatment Patterns of Medicare Beneficiaries with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

    Jul 1, 2022, 00:00

  • EPH113 Treatment Patterns in Patients Newly Diagnosed with Schizophrenia with Commercial Versus Medicaid Insurance Coverage

    Jul 1, 2022, 00:00

  • MSR26 Review of Existing AI-Based Automatic Tools for Evidence Synthesis

    Jul 1, 2022, 00:00

  • EE353 The Economic Burden of Anticholinergic Use in Adults with Overactive Bladder in the United States: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • CO111 Inpatient Healthcare Resource Use Outcomes Among Patients Living with Chronic Kidney Disease and Anemia in the United States

    Jul 1, 2022, 00:00

  • HSD24 Barriers and Facilitators of Reporting Adverse Drug Reaction Among Hospital Pharmacists in Nigeria and USA

    Jul 1, 2022, 00:00

  • CO75 Predictors of Value-Based Outcomes in Sepsis: An Analysis Using Electronic Health Record and Administrative Claims Data

    Jul 1, 2022, 00:00

  • EPH85 Mortality and Health Care Utilization Trends of Cardiovascular Diseases: Comparing Hungary to OECD Average

    Jul 1, 2022, 00:00

  • MSR16 A Methodological Framework to Account for the Impact of Non-Adherence on the Cost-Effectiveness of Chronic Medications

    Jul 1, 2022, 00:00

  • EE321 A Re-Examination of a Cost-Minimization Analysis in Multiple Sclerosis: Assessing Biases from the Inaccurate Assumption of Equal Effectiveness Using Probabilistic Sensitivity Analysis (PSA)

    Jul 1, 2022, 00:00

  • EE313 Cost-Effectiveness Analysis of Resmetirom: An Investigational Treatment for the Management of Nonalcoholic Steatohepatitis

    Jul 1, 2022, 00:00

  • EPH67 Comparisons of Twenty-Year Trends in Direct Costs, Absence Payments and Lost Time for Employee "Caregivers” of Patients with Breast, Skin, GI, Female, Male, and "Other” Cancers

    Jul 1, 2022, 00:00

  • EE18 A Cost-Effectiveness Analysis for High Versus Low Dose Caffeine for the Treatment of Apnea in Neonatal Intensive Care Unit

    Jul 1, 2022, 00:00

  • HTA30 Paying for Digital Health Interventions: A Rapid Review of Payers' Evidence Frameworks

    Jul 1, 2022, 00:00

  • Editorial Board

    Jul 1, 2022, 00:00

  • EE362 Microcosting of Cataract Surgery Complications from a US Provider Perspective

    Jul 1, 2022, 00:00

  • EE249 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Costa Rica

    Jul 1, 2022, 00:00

  • Exploration of the Reasons Why Health State Valuation Differs for Children Compared With Adults: A Mixed Methods Approach

    Jul 1, 2022, 00:00

  • EPH35 Information Seeking and Preventive Behavior during the COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • HTA49 Determining Appropriate Health Economic Modeling Approaches in Fabry Disease

    Jul 1, 2022, 00:00

  • CO45 Impact of Smoking Status on the Combination of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Antiangiogenic Agents in Advanced Non-Small-Cell Lung Cancer Harbored Susceptible EGFR Mutation: A Systematic Review ...

    Jul 1, 2022, 00:00

  • HTA13 Updating Nice Evidence Standards Framework for the Effectiveness and Economic Impact of Digital Health Technologies

    Jul 1, 2022, 00:00

  • EE149 Predicting the Population Budget Impact of Current and New Listings for Colorectal Cancer: The PRIMCAT-CRC Model

    Jul 1, 2022, 00:00

  • EPH71 Uses of Antiepileptic Drugs Among Pregnant Women with Epilepsy in Taiwan, a 15-Year Cohort Study

    Jul 1, 2022, 00:00

  • Disclaimer

    Jul 1, 2022, 00:00

  • EE3 Cost-Effectiveness of Intravenous Antibiotics Therapy for Children with Acute Gastroenteritis in a Secondary Care Hospital in South India

    Jul 1, 2022, 00:00

  • CO110 Comparative Effectiveness of Sertraline, Fluoxetine Vs Escitalopram Among Adults with Depression in the United States

    Jul 1, 2022, 00:00

  • Cost Effectiveness Analysis in Oncology Studies

    Jul 1, 2022, 00:00

  • HSD103 Prescribing Patterns and Predictors of Opioid Prescription Among Outpatients with Osteoarthritis in the United States

    Jul 1, 2022, 00:00

  • EPH107 An Evaluation of the Relationship between QTc Prolonging Medications, Tisdale Risk Scores and Mortality Using a Nationally Representative Electronic Health Records Database

    Jul 1, 2022, 00:00

  • MSR13 Comparison of Three Network Meta-Analysis Methods Based Non-Ph in a Cost-Effectiveness Considering Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

    Jul 1, 2022, 00:00

  • HSD82 Vitiligo: Trends in Real-World Treatment Patterns in the United States

    Jul 1, 2022, 00:00

  • EE332 A Budget Impact Model for Terlipressin in Treating Bleeding Oesophageal Varices Patients in the Philippines

    Jul 1, 2022, 00:00

  • HSD17 Relationship between BMI and Healthcare Costs in a Commercial and Medicare Population

    Jul 1, 2022, 00:00

  • HTA48 Minimum Follow-up Time Required for the Detection of the Impact of Treatments on Neuropathic Pain and Gastrointestinal Complaints in Fabry Disease

    Jul 1, 2022, 00:00

  • CO102 Effectiveness of Short Term Neoadjuvant Endocrine Therapy on KI67 in Luminal Breast Cancers

    Jul 1, 2022, 00:00

  • EE28 Annual Health Insurance Treatment Cost of Female Infertility of Other Origin Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HPR3 To Wait or Not to Wait: Foregone Option Value for Cell and Gene Therapies

    Jul 1, 2022, 00:00

  • EE84 A Reexamination of Drug Costs for Cetuximab and Panitumimab in Metastatic Colorectal Cancer: Assessing the Influence of Drug Vial Splitting

    Jul 1, 2022, 00:00

  • HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan

    Jul 1, 2022, 00:00

  • EE293 Diagnostic Hospitalization and Associated Costs in Patients with Amyloid Light-Chain Amyloidosis

    Jul 1, 2022, 00:00

  • HTA45 Care for Rare: Market Access Evidentiary Requirements for Rare Cancers

    Jul 1, 2022, 00:00

  • EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community

    Jul 1, 2022, 00:00

  • HSD63 Real-World Crizanlizumab Treatment Patterns of Patients with Sickle Cell Disease

    Jul 1, 2022, 00:00

  • EE260 Early Albumin Infusion May Reduce Intensive Care Unit (ICU) Cost in Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP): A Cross-Sectional Study

    Jul 1, 2022, 00:00

  • EPH93 Treatment Patterns of Triple Negative Breast Cancer in Brazilian Private Healthcare Setting: a Claim Database Study

    Jul 1, 2022, 00:00

  • EE132 Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina

    Jul 1, 2022, 00:00

  • CO98 Midodrine Use As an Adjunct Therapy to Intravenous Vasopressors in Critically Ill Patients

    Jul 1, 2022, 00:00

  • CO29 Subsidized Screening and Lifestyle Management of Gestational Diabetes Mellitus in Rural China: A Multi-Centre, Randomized Controlled Trial

    Jul 1, 2022, 00:00

  • CO85 Medication and Education Compliance in Type II Diabetes

    Jul 1, 2022, 00:00

  • EPH95 Frequency of and Testing Patterns for Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (DMMR) Among Solid Tumors in a US Community Oncology Setting

    Jul 1, 2022, 00:00

  • EE394 Outcomes and Costs Associated with Central Venous Catheter-Related S. Aureus Bloodstream Infections in Adult Hemodialysis Patients with S. Aureus Nares Colonization

    Jul 1, 2022, 00:00

  • EE412 The Journey to Autism Spectrum Disorder Diagnosis: An Examination of Time, Healthcare Utilization, and Costs

    Jul 1, 2022, 00:00

  • EE99 Economic Burden of COVID-19 in Mexico

    Jul 1, 2022, 00:00

  • EE222 Indirect Cost Associated with Stroke-Related Disability: The Role of Learning Curves for Mechanical Thrombectomy in Improving Outcomes and Costs in Chile

    Jul 1, 2022, 00:00

  • EE307 Orbital Atherectomy System (OAS) with Angioplasty for Critical Lower LIMB Ischemia Treatment. Budget IMPACT Analysis: From a Modelling Approach to a Hospital Reality in Italy

    Jul 1, 2022, 00:00

  • EE140 Estimated Costs for All-Cause Grade 3/4 Adverse Events Among First-Line Tyrosine Kinase Inhibitor Plus Immuno-Oncology-Based Combination Therapies for Patients with Advanced Renal Cell Carcinoma from the United States Perspective

    Jul 1, 2022, 00:00

  • EE143 Cost-Effectiveness of Belantamab Mafodotin (BELAMAF) VS. Melphalan Flufenamide in Combination with Dexamethasone (MEL+DEX) in Heavily PRE-Treated Relapsed/Refractory Multiple Myeloma Patients: A U.S. Payer Perspective

    Jul 1, 2022, 00:00

  • EE254 Biosimilars Impact on the Rheumatoid Arthritis Treatment: A Cost-Effectiveness Model from Spanish National Healthcare System Perspective

    Jul 1, 2022, 00:00

  • EE142 Cost-Effectiveness Analysis of Biosimilars Based Treatment Sequences for Moderate-to-Severe Crohn Disease in Spain

    Jul 1, 2022, 00:00

  • EPH81 Statural Growth of at Term Newborns with Intrauterine Growth Retardation: A Prospective Cohort Study in Algeria

    Jul 1, 2022, 00:00

  • HPR15 Cause and Cure: Weighing the Prospective Impact of Cures 2.0 ACT Breakthrough Device Coverage on a Linked US Regulatory and Payer Framework

    Jul 1, 2022, 00:00

  • CO114 Real-World Reductions in Acute Medication Use for Patients with Migraine Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis

    Jul 1, 2022, 00:00

  • EE369 IgA Nephropathy (IGAN) in Adults: A Retrospective Analysis of US Prevalence and Impacts of Proteinuria and Kidney Function Decline on Healthcare Resource Utilization (HRU) and Costs

    Jul 1, 2022, 00:00

  • EPH76 Prevalence and Predictors of Prediabetes in a Multiethnic Society

    Jul 1, 2022, 00:00

  • EE462 Value-Based Pricing for Patent-Protected Medicines: Pricing Anomalies in the "Age of Cures” and Their Implications for Dynamic Efficiency

    Jul 1, 2022, 00:00

  • EE220 Comprehensive Nutrition Program Informs Potential Cost-Savings for Latin American Hospitals: A Budget Impact Analysis

    Jul 1, 2022, 00:00

  • EPH69 Cancers Treatment from Their Perspective: A Qualitative Pilot Study Exploring the Knowledge Attitude and Practice of Folk Medicine Practitioners in a Low-and-Middle-Income-Country

    Jul 1, 2022, 00:00

  • EE242 Economic Burden Among Chronic Kidney Disease (CKD) Patients with and without Type 2 Diabetes (T2D) in a Commercially Insured/Medicare Advantage (MA) Population in the United States (US)

    Jul 1, 2022, 00:00

  • EE127 Economic Impact of Balloon Guide Catheter Use with Mechanical Thrombectomy for Acute Ischemic Stroke: A U.S. Payer Perspective Cost Analysis

    Jul 1, 2022, 00:00

  • EE80 Cost-Effectiveness Analysis of Hemodialysis Vs. Peritoneal Dialysis Among Patients with End-Stage Renal Disease

    Jul 1, 2022, 00:00

  • HSD132 Using the Theory of Planned Behavior to Predict Asthma Treatment Adherence Among Parents of Children Diagnosed with Asthma

    Jul 1, 2022, 00:00

  • CO137 Real-World Outcomes Associated with Bezlotoxumab Use Among Medicare Beneficiaries with Clostridioides Difficile Infection

    Jul 1, 2022, 00:00

  • MSR47 Feasibility Assessment of Indirect Treatment Comparison of Biologics for Treating Chronic Rhinosinusitis with Nasal Polyps

    Jul 1, 2022, 00:00

  • MSR11 A Step-By-Step Guide for Causal Study Design When Estimating Treatment Effects Using Real-World Data

    Jul 1, 2022, 00:00

  • Valuing Child Health Isn’t Child’s Play [Editor's Choice]

    Jul 1, 2022, 00:00

  • HPR22 Copayment for Prescription Drugs Under Taiwan's National Health Insuran A Cross-Sectional Study, 2008-2017

    Jul 1, 2022, 00:00

  • EPH79 Projections of Future Health and Economic Burden of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus in Australia. Estimates up to 2030

    Jul 1, 2022, 00:00

  • EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata

    Jul 1, 2022, 00:00

  • HSD108 Pharmacist Intention to Provide Palliative Care Services in Saudi Arabia

    Jul 1, 2022, 00:00

  • EPH94 Prevalence and Factors Associated with Complementary and Alternative Medicine (CAM) and Prescription Drugs Use in Adults with Inflammatory Chronic Conditions (ICC)

    Jul 1, 2022, 00:00

  • HSD67 The Burden of Systemic Glucocorticoid (GC) Use in Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis Patients

    Jul 1, 2022, 00:00

  • EPH167 Recursive Partitioning Analysis of COVID-19 Risk and Behavioral Measures in an Urban Setting

    Jul 1, 2022, 00:00

  • CO107 Progression-Free Survival in Patients with Advanced or Metastatic, Hormone Receptor Positive, HER2-Negative Breast Cancer Treated with Palbociclib in Combination with Fulvestrant: A Real-World Study

    Jul 1, 2022, 00:00

  • HTA3 Passport for Travel: Proposed Framework for Transportability of Oncology Real World Evidence

    Jul 1, 2022, 00:00

  • EE106 Evaluation of Full Factorial and Latin Hypercube Sampling As Alternatives to Traditional Random Selection for Probabilistic Uncertainty Analyses

    Jul 1, 2022, 00:00

  • EE507 Accuracy of Transferred Medical Costs: Evidence from the Middle East and North Africa Region

    Jul 1, 2022, 00:00

  • EPH80 Epidemiological Disease Burden and Cost of Illness of Autism in the US

    Jul 1, 2022, 00:00

  • EE34 Comparing the Cost-Effectiveness of the Otago Exercise Programme Among Older Women and Men: A Secondary Analysis of a Randomized Controlled Trial

    Jul 1, 2022, 00:00

  • EE96 Using Multi-State Modelling for Health Economic Evaluations

    Jul 1, 2022, 00:00

  • HSD33 Patient Utilization and Switching Patterns of Patient Assistance Programs (PAPs) for Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide (CGRP) Pathway for Migraine Prevention: A Retrospective Cohort Study

    Jul 1, 2022, 00:00

  • CO43 Identifying Co-Morbidity, Outcomes, Hospital Utilization, and Racial Differences in Patients Ages 18-64 with Colorectal Cancer That Were Hospitalized between 2016 and 2019

    Jul 1, 2022, 00:00

  • MSR36 Developing the Consolidated Health Outcomes/Interventions Choice-Modeling Evaluation Standards (CHOICES): A Content Analysis

    Jul 1, 2022, 00:00

  • P58 Measuring the Real-World Impact of Subsidy Decision on Clinical Practice and Patient Outcomes: Post-Subsidy Evaluation of Sofosbuvir/Velpatasvir for Treating Chronic Hepatitis C

    Jul 1, 2022, 00:00

  • HSD100 HER2 and Other Biomarker Testing Patterns Among Patients with Advanced Gastric Cancer (GC) or Gastric Esophageal Junction Cancer (GEJC)

    Jul 1, 2022, 00:00

  • Epidemiology Public Health

    Jul 1, 2022, 00:00

  • CO26 Efficacy and Safety of First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison

    Jul 1, 2022, 00:00

  • EE144 Real-World Economic Evaluation of Prospective Rapid Whole-Genome Sequencing Compared to a Matched Retrospective Cohort of Critically Ill Pediatric Patients in the United States

    Jul 1, 2022, 00:00

  • EPH118 Incidence of Human Papillomavirus (HPV)-Related Cancers before and after HPV Vaccine Introduction Among Males and Females 15-44 Years Old in the US

    Jul 1, 2022, 00:00

  • HTA41 Consequences of Brexit: Medicines Access to Northern Ireland

    Jul 1, 2022, 00:00

  • EE470 Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical Trial

    Jul 1, 2022, 00:00

  • HTA17 An Algorithmic Theory of Value-Based Price Adjustment Using Incremental Cost-Effectiveness Ratio: Regarding a Real-World Case in Japan

    Jul 1, 2022, 00:00

  • HPR44 HTA in the Private Health Insurance Sector in Brazil: Document Analysis

    Jul 1, 2022, 00:00

  • CO77 Efficacy of PD1/PD-L1 Inhibitors VS Chemotherapy As First-Line Treatment of Non-Small Cell Lung Cancer Among Patients with Different PD-L1 Expression Levels

    Jul 1, 2022, 00:00

  • HSD104 Antibiotics Dispensed at Drugstores for Mild Cases of COVID-19 Patients in Northern Punjab, Pakistan

    Jul 1, 2022, 00:00

  • MSR7 Evaluating the Impact of Weighted Sample Size on Matching Adjusted Indirect Treatment Comparisons between Trials with Time-to-Event Outcome: A Simulation Study

    Jul 1, 2022, 00:00

  • Studies on COVID-19 Healthcare Impacts

    Jul 1, 2022, 00:00

  • HSD88 Fruit and Vegetable Consumption in Hungary during the Fall of COVID-19 Pandemic in 2020

    Jul 1, 2022, 00:00

  • EE29 Annual Health Insurance Treatment Cost of Female Infertility Associated with Male Factors Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • CO79 Predictors of Outcomes Measured after Loss of Ambulation in Duchenne Muscular Dystrophy: A Literature Review and Grading of the Evidence

    Jul 1, 2022, 00:00

  • EE336 Budget Impact Analysis of Nefecon for the Treatment of Primary IgA Nephropathy in the United States

    Jul 1, 2022, 00:00

  • EE497 Real-World Healthcare Resource Utilization and Associated Costs in Patients with Eosinophilic Esophagitis

    Jul 1, 2022, 00:00

  • EE190 Cost-Effectiveness of Dapagliflozin Alone or in Combination with Saxagliptin Added to Standard of Care for the Management of Diabetic Kidney Disease in the United States

    Jul 1, 2022, 00:00

  • EPH159 Burden of Ischemic Heart Disease in Colombia: A Simulation from a Live-Birth Cohort

    Jul 1, 2022, 00:00

  • EPH5 Prevalence of Hematuria and Its Association with Urinary Tract Cancer: A Case-Control Study Using Real-World Data from UK Primary Care

    Jul 1, 2022, 00:00

  • EPH157 The Impact of BRAF V600E Mutation and Microsatellite Instability on Overall Survival (OS) in Metastatic Colorectal Cancer (MCRC)

    Jul 1, 2022, 00:00

  • HSD112 Uptake of Newer Second-Line Diabetes Medications in Real-World Vulnerable Populations

    Jul 1, 2022, 00:00

  • HPR5 Price and Volume Changing Trends of Medicines Based on Index Analysis: An Empirical Case from Shanghai

    Jul 1, 2022, 00:00

  • EPH74 Epidemiological Disease Burden and Cost of Illness of Systemic Lupus Erythematosus (SLE) in the US

    Jul 1, 2022, 00:00

  • HPR37 Achieving Better Birth Outcomes Among Black Women: A Linked EMR/Claims Analysis of Visit History and Outcomes

    Jul 1, 2022, 00:00

  • EPH78 Beliefs Regarding HPV Vaccination Among Young Adult College Students: A Qualitative Study

    Jul 1, 2022, 00:00

  • EPH156 Iron Deficiency Anaemia Among Blood Donors in Algeria: A Cross-Sectional Survey

    Jul 1, 2022, 00:00

  • HPR38 Drug Spending and Medication Use after Implementing a Formulary That Incorporates Formal Value Assessment

    Jul 1, 2022, 00:00

  • EE252 Costing Analysis of Early Childhood Development Project of the Integrated Maternal and Child Health and Development Programme (2017-2020)

    Jul 1, 2022, 00:00

  • EPH127 Systematic Literature Review of the Humanistic and Economic Impact of Angelman Syndrome

    Jul 1, 2022, 00:00

  • EE324 Economic Burden of Chronic Kidney Disease in Type 2 Diabetes: A Systematic Review of the Literature

    Jul 1, 2022, 00:00

  • EE166 Cost-Effectiveness of Treatment Strategies for Severe Hemophilia a Patients in the United States

    Jul 1, 2022, 00:00

  • EPH150 Epidemiological Disease Burden of Female Infertility Associated with Anovulation Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HSD92 Natural Language Processing (NLP) of Unstructured EMR Data to Describe Treatment Patterns and Achievement of Guideline Recommended LDL-C Targets of Canadian Patients with Ascvd and Hypercholesterolemia

    Jul 1, 2022, 00:00

  • EE364 Cost-Effectiveness of Ferric Carboxymaltose for Treating Iron Deficiency Anemia in China

    Jul 1, 2022, 00:00

  • EE227 Systematic Review on Cost-Effectiveness of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

    Jul 1, 2022, 00:00

  • P15 Drivers of Health Disparities and Consequences for COVID-19 Vaccine Choices: Modelling Health Preference Heterogeneity Among Underserved Populations

    Jul 1, 2022, 00:00

  • EE445 Annual Health Insurance Treatment Cost of Polycystic Ovary Syndrome Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HSD16 Trends in Rheumatology Patient Care and Practice Operations Pre- and Post-COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • EE483 The Economic Impact of Coronavirus Pandemic on Stroke Care: Direct and Indirect Costs Estimations in Chile

    Jul 1, 2022, 00:00

  • HPR54 International Coverage and Financing Strategies for the Treatment of Obesity: A Scoping Review

    Jul 1, 2022, 00:00

  • P2 Faster Access to Innovative Therapies with Risk-Sharing Agreements - Cancer Medication Reimbursement Decisions from January 2012 to November 2021 in Finland

    Jul 1, 2022, 00:00

  • HSD95 Real-World Treatment Patterns and Healthcare Resource Utilization Among Patients Diagnosed with Erythropoietic Protoporphyria and X-Linked Protoporphyria: Results from a US Electronic Medical Records Study

    Jul 1, 2022, 00:00

  • Emerging Methods in Economic Evaluations

    Jul 1, 2022, 00:00

  • EE50 Olaparib As Maintenance Therapy for Women with Ovarian Cancer and Homologous Recombination Deficiency in Brazil: What Clinical and Cost Data Have Highest Impact on Cost-Effectiveness Analysis?

    Jul 1, 2022, 00:00

  • EE178 CEA of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China

    Jul 1, 2022, 00:00

  • EPH171 Association of Multimorbidity with Use of Health Information Technology

    Jul 1, 2022, 00:00

  • EE413 Budget Impact Analysis of Macimorelin, an Oral Growth Hormone Stimulation Test, As a Diagnostic Test for Adult Growth Hormone Deficiency (AGHD) across 5 European Countries

    Jul 1, 2022, 00:00

  • EPH126 Association of Depressive Symptoms and Suicidal Ideation with Impulsive Choi Findings from Nationally Representative Survey

    Jul 1, 2022, 00:00

  • EE498 Economic Burden of Interstitial Lung Disease in a Commercially Insured Population with Sjogren's Syndrome in the United States

    Jul 1, 2022, 00:00

  • EE139 Using a User-Friendly Modeling Tool to Inform and Guide Local Decision-Making for Lynch Syndrome Screening at Healthcare Systems

    Jul 1, 2022, 00:00

  • EPH88 Epidemiological Disease Burden of Ovarian Endometriosis Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • CO88 Center-Level Variation in Treatment Satisfaction Questionnaire for Medication (TSQM) Scores in Patients with MS from the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative Study (2017-2020)

    Jul 1, 2022, 00:00

  • EE434 Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer

    Jul 1, 2022, 00:00

  • EE212 Cost-Effectiveness of Pneumococcal Vaccination Implementation in Older Adult Immunization Schedule in the Brazilian National Program

    Jul 1, 2022, 00:00

  • HTA70 Forecasting Drug Price for Reimbursement By Utilizing a Value-Price Relationship, a Case Study in Hormone-Relapsed Prostate Cancer

    Jul 1, 2022, 00:00

  • EE97 Population Discordance in Economic Evaluations of Polygenic Risk Scores

    Jul 1, 2022, 00:00

  • EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL

    Jul 1, 2022, 00:00

  • HTA55 Use of Surrogate Endpoints for Obtaining Accelerated Approval - a Market-Level Descriptive Analysis

    Jul 1, 2022, 00:00

  • EE241 Clinical Pharmacist Dosage-Adjustment Interventions in Egyptian Hospitals: Do They Save Costs?

    Jul 1, 2022, 00:00

  • EPH109 A Scoping Review of Interactive Online Decision Tools to Guide Surgery and Adjuvant Treatment Decisions in Breast Cancer

    Jul 1, 2022, 00:00

  • HSD93 Trends in the Use of Biologics for Treatment of Psoriatic Arthritis

    Jul 1, 2022, 00:00

  • HPR66 Cost Savings Associated with One-Stage vs Two-Stage Spinal Cord Stimulation from Medicare Perspective

    Jul 1, 2022, 00:00

  • HSD41 2015 American Thyroid Association Guidelines and Outcomes for Patients with Thyroid Cancer

    Jul 1, 2022, 00:00

  • EE309 Pharmacoeconomic and Pharmacoepidemiological Analysis of the Use of Drugs in an Anti-Tuberculosis Hospital Based on the Local Real-World Data

    Jul 1, 2022, 00:00

  • MSR4 Implications of Cure Fractions on Costs of Cancer Care: An Innovative Application to Multi-Cancer Early Detection (MCED) Economic Modeling

    Jul 1, 2022, 00:00

  • EPH165 Comparisons of Twenty-Year Trends in Direct Costs, Absence Payments and Lost Time for Employees with Breast, Skin, GI, Female, Male, and "Other” Cancers

    Jul 1, 2022, 00:00

  • EPH61 Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD)

    Jul 1, 2022, 00:00

  • EE372 Cost-Utility of Ribociclib As the First-Line Treatment in Postmenopausal Women with Hormone Receptor Positive and Human Epidermal Growth Factor Receptor-2 Negative Advanced/Metastatic Breast Cancer in Colombia

    Jul 1, 2022, 00:00

  • CO105 Does Preoperative Chest Physiotherapy Affect the Postoperative Pulmonary Complications and Lung Functions in Patients Undergoing Elective Cardiac Surgery? a Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • HSD64 The Influence of COVID-19 on Telemedicine Services Among Blue Cross and Blue Shield of Louisiana Members with Diabetes

    Jul 1, 2022, 00:00

  • Economic Evaluation of Disease Burden Using Real World Data

    Jul 1, 2022, 00:00

  • P51 Osteoarthritis Affecting Health-Related Quality of Life Among Older Patients

    Jul 1, 2022, 00:00

  • HTA74 Could Artificial Intelligence Support Prediction of Reimbursement Decisions in Scotland? A Pilot Project

    Jul 1, 2022, 00:00

  • EE157 National Implementation of a Lifestyle Intervention to Reduce Gestational Weight Gain Provides Large Returns on Investment: A Budget Impact Analysis for Australia

    Jul 1, 2022, 00:00

  • CO25 Effects of Pharmacist Interventions on Pain Intensity: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Jul 1, 2022, 00:00

  • EE474 Cost-Effectiveness Model for a Novel Functional ASSAY Versus Provider Selection of Third-Line Treatment of Patients with Refractory Metastatic Colorectal Cancer

    Jul 1, 2022, 00:00

  • HSD32 Using Natural Language Processing (NLP) of Unstructured EMR Data to Describe Canadian Patients with Familial Hypercholesterolemia (FH) and Their Management

    Jul 1, 2022, 00:00

  • HSD86 Association between Medicare Beneficiaries’ Perceptions of Their Physicians and Discussion of Urinary Incontinence

    Jul 1, 2022, 00:00

  • EE20 An Overview of Optimisation Studies on COVID-19 and Its Economic Benefits in India

    Jul 1, 2022, 00:00

  • EE123 Budget Impact Analysis of Sacral Neuromodulation in Fecal Incontinence in Obras Sociales and Empresas De Medicina Prepaga in Argentina

    Jul 1, 2022, 00:00

  • EPH32 Perceived Risk of COVID-19 and Its Association with Preparedness and Preventive Practices: A Latent Class Segmentation Analysis

    Jul 1, 2022, 00:00

  • P31 Feasibility of Using Oncology Specific Electronic Health Records (EHR) Data to Emulate Clinical Trial Inclusion and Exclusion Criteria

    Jul 1, 2022, 00:00

  • P70 Evaluation of Cost and Health Utilization Outcomes of Medicare Beneficiaries Enrolled in a Medication Synchronization Program

    Jul 1, 2022, 00:00

  • EPH58 The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala

    Jul 1, 2022, 00:00

  • EE415 Spatial Cost-Efficiency Analysis on the Separability Condition of COVID-19 Potential Determinants

    Jul 1, 2022, 00:00

  • Health Technology Assessment

    Jul 1, 2022, 00:00

  • EE201 Cost-Effectiveness of Romiplostim for the Treatment of Patients with Early Immune Thrombocytopenia in the Czech Republic

    Jul 1, 2022, 00:00

  • EE206 Cost of Neuromyelitis Optica Spectrum Disorder Misdiagnosis

    Jul 1, 2022, 00:00

  • HSD119 Persistence to Treatment with Initially Prescribed Antiplatelet Agents for the Onset of Acute Coronary Syndrome

    Jul 1, 2022, 00:00

  • EPH53 Epidemiological Disease Burden of Unspecified Female Infertility Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • Economic Evaluation

    Jul 1, 2022, 00:00

  • MSR21 Cost-Effectiveness Analysis of Treatments for Nonsense Mutation Duchenne Muscular Dystrophy: Expert Validation of Model Face Validity

    Jul 1, 2022, 00:00

  • Evidence on Treatment Access, Disparities and Social Determinants of Health

    Jul 1, 2022, 00:00

  • EE158 Budget Impact of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder from a US Payer Perspective

    Jul 1, 2022, 00:00

  • EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis

    Jul 1, 2022, 00:00

  • HPR47 Impact of Zero-Dollar Copayment and Premium Changes on Medication Adherence in Diabetic Patients in an Employee Health Group

    Jul 1, 2022, 00:00

  • MSR18 The Effect of Weight Loss on Hypothalamus Structure and Function in Obese Individuals: A Systematic Literature Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • HSD8 Real-World Patient Persisten A Comparison of Prostaglandin Analogs Used for the Treatment of Open-Angle Glaucoma or Ocular Hypertension

    Jul 1, 2022, 00:00

  • EE352 Projecting the Incidence and Costs of Major Cardiorenal Complications of Type 2 Diabetes with Widespread GLP-1 RA and SGLT2I Use

    Jul 1, 2022, 00:00

  • HSD89 Impact of Race on Utilization of First Vs Second Generation Long-Acting Injectable Antipsychotics Among Medicaid Beneficiaries with Schizophrenia

    Jul 1, 2022, 00:00

  • EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital

    Jul 1, 2022, 00:00

  • CO81 Episode of Care Assurance Program (ECAP) Results in Significantly Reduced Readmissions for Patients Undergoing Primary Total Joint Replacement Surgery

    Jul 1, 2022, 00:00

  • EPH30 Economic Burden of Adverse Events Associated with Erythropoiesis-Stimulating Agents for the Treatment of Anemia Among Chronic Kidney Disease Patients in Taiwan

    Jul 1, 2022, 00:00

  • MSR44 A Machine Learning Aided Systematic Review of Screen Media Use and Executive Functions Among Children and Adolescents

    Jul 1, 2022, 00:00

  • EE458 Health Care Resource Utilization and Costs of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Claims Database Analysis in the US

    Jul 1, 2022, 00:00

  • HPR28 Assessment of the French National Experimentation for Incentivising Hospital Prescriptions of Etanercept Biosimilars Delivered in Retail Pharmacies

    Jul 1, 2022, 00:00

  • P64 Cost-Utility Analysis Comparing Mastectomy and Lumpectomy in Early Stage Breast Cancer Surgeries in Sweden - a Life-Time Approach Using Markov Modelling

    Jul 1, 2022, 00:00

  • EPH6 Health-Related Quality of Life (HRQOL) Among Chinese Population during the COVID-19 Pandemic: The Role of Socio-Demographic Factors and Loneliness

    Jul 1, 2022, 00:00

  • CO73 Association of Antipsychotic Treatment Adherence and Switching with Healthcare Utilization Using Medical Records Data

    Jul 1, 2022, 00:00

  • CO70 Change in KI-67 Index in Patients Receiving Preoperative Endocrine Therapy Among Hormone Positive Breast Cancer Patients: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • P26 Unintended Consequences of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain for the Individuals with Sickle Cell Disease

    Jul 1, 2022, 00:00

  • EE238 Healthcare Costs of COVID-19 Versus Flu and Pneumonia - a Payer Perspective

    Jul 1, 2022, 00:00

  • HSD13 Factors Associated with Prescribing of Teriflunomide and Dimethyl Fumarate Versus Fingolimod in Multiple Sclerosis

    Jul 1, 2022, 00:00

  • EE208 Cost-Effectiveness of a Digital Wellness Intervention for Managing Depression and Anxiety: A Payer Perspective

    Jul 1, 2022, 00:00

  • CO20 Costs Analysis, Effectiveness and Safety Associated with Chimeric Antigen Receptor (CAR)-T Cell Therapy: Results from a Portuguese Comprehensive Cancer Center

    Jul 1, 2022, 00:00

  • Methods for Early Assessment of the Societal Value of Health Technologies: A Scoping Review and Proposal for Classification [Editor's Choice]

    Jul 1, 2022, 00:00

  • EE277 Cost-Effectiveness Analysis of National Smoking Cessation Service Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Thailand

    Jul 1, 2022, 00:00

  • EE23 Translation, Cross-Cultural Adaptation and Psychometric Testing of a Yoruba Version of the EQ-5D Questionnaire in Patients with Musculoskeletal Disorders

    Jul 1, 2022, 00:00

  • CO6 Clinical and Economic Outcomes of Adult Limb Spasticity Treatment with Botulinum Toxin-a (BONT-A) Products: A Single-Center Non-Interventional Retrospective Study

    Jul 1, 2022, 00:00

  • HPR61 Impact of an Imatinib Volume-Based Purchase Policy (VBP) on the Use of Tyrosine Kinase Inhibitors (TKI) for Chronic Myeloid Leukemia (CML) in Chinese Tertiary Care Hospitals: A Retrospective Analysis

    Jul 1, 2022, 00:00

  • EE401 Productivity Loss and Indirect Costs Associated with Migraine and Probable Migraine in Korea

    Jul 1, 2022, 00:00

  • EPH164 Illness Severity Associated with Comorbid Substance Use Disorders in Schizophrenia: An Electronic Health Record Study

    Jul 1, 2022, 00:00

  • P74 Real-World Comparative Effectiveness of Pegfilgrastim Biosimilars Versus Originator

    Jul 1, 2022, 00:00

  • HSD117 Sociodemographic Disparities in COVID-19 Vaccinations Still Exist 1 Year Following Vaccine Rollout

    Jul 1, 2022, 00:00

  • EE266 Integrating Royston-Parmar Flexible Parametric Survival Models for Time Dependent Hazard Rates into Microsoft Excel for Health Economic Modelling

    Jul 1, 2022, 00:00

  • EE418 Burden of Illness Analysis of Fracture Female Patients with Postmenopausal Osteoporosis in China: A Retrospective Electronic Medical Record Database Analysis

    Jul 1, 2022, 00:00

  • EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine

    Jul 1, 2022, 00:00

  • EE131 Health-Economic Evaluation of Early Screening for Individuals Younger Than Age 50 with Familial Colorectal Cancer Risk Based on a Decision Analysis within the Farkor Study

    Jul 1, 2022, 00:00

  • EE189 CAPOX versus mFOLFOX as Adjuvant Chemotherapy in Patients with Stage 3 Colon Cancer: A Cost-Effectiveness Study

    Jul 1, 2022, 00:00

  • EE203 Clinical and Economic Outcomes of Patients with Multiple Rib Fractures Treated Operatively Vs. Non–Operatively — a US Hospital Database Analysis

    Jul 1, 2022, 00:00

  • EE234 Advantages of Visualizing Net Loss Curves in Cost Effectiveness Analyses: An Example Comparing Opioid Use Disorder Treatment Alternatives

    Jul 1, 2022, 00:00

  • EPH52 Cause-Specific Mortality Among Patients with Hemophilia: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EE489 Cost-Effectiveness of 3-Antigen Vs. Single-Antigen Vaccine for Prevention of Hepatitis B in Adults in the United States

    Jul 1, 2022, 00:00

  • CO121 The Impact of Clinical Trial Participation on Patients with Metastatic Breast Cancer

    Jul 1, 2022, 00:00

  • EE440 Economic Evaluation of Nefecon in Primary IgA Nephropathy in The United States

    Jul 1, 2022, 00:00

  • HSD3 Choosing Wisely? Use of Intensity Modulated Radiation Therapy Following Lumpectomy in Early-Stage Breast Cancer: A Seer-Medicare Analysis

    Jul 1, 2022, 00:00

  • EPH7 Racial Disparities in Colorectal Cancer Outcomes: How Community Health Workers Can Increase Screening Uptake in the US

    Jul 1, 2022, 00:00

  • EE243 Economic Evaluation of Lidocaine Patches for the Treatment of Localized Neuropathic Pain from Mexican Public Health System Perspective

    Jul 1, 2022, 00:00

  • HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia

    Jul 1, 2022, 00:00

  • HPR55 How Inequities and Disparities in Health Healthcare Are Impacting COVID-19 Outcomes: A Scoping Review

    Jul 1, 2022, 00:00

  • EE358 Transparency and Utility of Using Net Monetary Benefit (NMB) Analysis over Incremental Cost-Effectiveness Ratios (ICERS): The Case of the Singapore Diabetes Prevention Program Cost-Effectiveness Analysis (CEA)

    Jul 1, 2022, 00:00

  • EE100 Treatment-Related Lost Productivity in Paroxysmal Nocturnal Hemoglobinuria: A Comparison of Investigational Subcutaneous Ravulizumab and Pegcetacoplan in the United States

    Jul 1, 2022, 00:00

  • CO12 Development of Frailty Index Using ICD-10 Codes to Predict Mortality and Rehospitalization of Older Adults: An Update of the Multimorbidity Frailty Index

    Jul 1, 2022, 00:00

  • EE269 Long-Term Cost-Effectiveness of a Pharmacist-Led Medication Therapy Management Clinic (MTMC) for Type 2 Diabetes Management

    Jul 1, 2022, 00:00

  • EPH75 COVID-19 Vaccine Breakthrough Infections in the United States, By Race

    Jul 1, 2022, 00:00

  • EE22 Financial Savings Associated with a Novel Bioprosthetic Engineered to Extend Device Durability Versus Mechanical Aortic Valve Replacements

    Jul 1, 2022, 00:00

  • EE388 Public Health and Economic Implications of Increasing Access to Herpes Zoster Vaccination Rate in Community Pharmacies

    Jul 1, 2022, 00:00

  • EPH11 Mortality and Health Care Utilization Trends of Diabetes Mellitus: Comparing Hungary to OECD Average

    Jul 1, 2022, 00:00

  • EE461 Cost of Biomarker Testing Among Patients with Metastatic Lung or Thyroid Cancer in the US: A Real-World Commercial Claims Database Study

    Jul 1, 2022, 00:00

  • P4 What Can the US Learn from Regulatory Decisions and Health Technology Assessments of New Drugs in Other Countries?

    Jul 1, 2022, 00:00

  • EE406 Households Direct Economic Burden Associated with Chronic Non-Communicable Diseases in Saudi Arabia

    Jul 1, 2022, 00:00

  • EE105 Triamcinolone Acetonide Injectable Suspension, for Suprachoroidal Use, for the Treatment of Macular Edema Associated with Uveitis in the United States: A Budget Impact Analysis

    Jul 1, 2022, 00:00

  • HSD118 A Retrospective Analysis of Treatment Patterns and Costs in Cytomegalovirus Management Among Transplant Recipients in the USA

    Jul 1, 2022, 00:00

  • HSD130 Utilization and Factors Associated with the Use of Alternative Pembrolizumab Dosing Regimens in Real-World: A US-Based EMR Study

    Jul 1, 2022, 00:00

  • HTA53 Combination Therapies: Two Is Company but Is Three (OR MORE) a Concern?

    Jul 1, 2022, 00:00

  • CO141 The Impact of Operative Approach on Postoperative Outcomes and Healthcare Cost Following Lobectomy for Lung Cancer Patients in Japan

    Jul 1, 2022, 00:00

  • EE486 A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

    Jul 1, 2022, 00:00

  • EE345 Health Insurance Treatment Cost of Female Infertility of Tubal Origin Based on Real-World Health Insurance Claims Data in 2019

    Jul 1, 2022, 00:00

  • EE422 Healthcare Costs Associated with Severe VS Moderate and Mild COVID-19 - a US Payer Perspective

    Jul 1, 2022, 00:00

  • EPH17 A Comprehensive Whole Disease Model: Targeted Literature Review and Feasibility Assessment in Schizophrenia

    Jul 1, 2022, 00:00

  • HTA47 Recommendations on Best Practices for Rwd Study Design to Support HTA Decision Process in Europe

    Jul 1, 2022, 00:00

  • HPR51 Administrative Processes Rather Than Care Delivery Key Indicators Are Being Used in the Brazilian National Agency for Private Healthcare System (ANS) Value-Based Healthcare (VBHC) Project?

    Jul 1, 2022, 00:00

  • EE305 Economic Burden in Adult Patients with Small Cell Lung Cancer (SCLC) Receiving Second-Line Therapy: A Systematic Literature Review (SLR)

    Jul 1, 2022, 00:00

  • EE333 Analysis of the Cost of Managing Patients with Advanced or Metastatic Non-Small Cell Lung Cancer in Argentina: Lorlatinib VS Alectinib

    Jul 1, 2022, 00:00

  • EPH50 Characterization of Clinical Features and Treatment of Non-Small Cell Lung Cancer (NSCLC) STAGE III and IV in Brazil- a Retrospective DATA-Base Study

    Jul 1, 2022, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29 (current)
  • 30
  • »